Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Theralink Technologies Inc THER

Healthcare Biotechnology
Theralink Technologies, Inc. is a proteomics-based, precision medicine company. The Company's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDT, the Theralink Assay for Breast Cancer, is utilized by oncologists across the United States to assist in making the targeted... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:THER)

Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates

GlobeNewswire December 18, 2023

Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4

GlobeNewswire November 13, 2023

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board

GlobeNewswire November 3, 2023

Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023

GlobeNewswire October 4, 2023

Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer

GlobeNewswire June 27, 2023

THERALINK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Theralink Technologies, Inc. - THER

Business Wire May 30, 2023

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company

PR Newswire May 23, 2023

Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

PR Newswire April 3, 2023

Theralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone

PR Newswire February 23, 2023
View More News ››

Opinion & Analysis (OTCPK:THER)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:THER)

LETTER OF INTENT

initiating trial of ProscaVax  Feb/2018
bolander - February 12, 2018

Corporate Update

Pretty lengthy, but an interesting read: http://www.marketwatch.com/story/oncbiomune-provides-corporate-update-nearly-50-drug...
gobig1 - May 9, 2017

News link.

https://www.google.ca/amp/www.marketwatch.com/amp/story/guid/189b9484-33f3-4e26-9cb5-abc073d6e3bf
zootv1 - March 30, 2017

News...

j
zootv1 - March 30, 2017

Big news . Sales Exceed forcast by 164%.

http://m.marketwired.com/press-release/oncbiomune-sales-bekunisr-cirkusedr-exceed-forecast-164-percent-first-six-months-on-otcqb-obmp...
zootv1 - March 27, 2017

OncBioMune Announces Cancer Vaccine Poster Presentation

http://us12.campaign-archive2.com/?u=6bd487a01f6c6deed74d5ab46&id=eee7a06618&e=d1dbe1943a
zootv1 - February 2, 2017
View more Bullboard ››

Silver Tiger Metals Inc

Silver Tiger Metals Inc

Silver Tiger Metals Inc. is a Canada-based company, which is engaged in exploring and developing the historic EL Tigre Mine ...
View More »